Skip to main content
    H

    Harte Hanks Inc (HHS)

    Official site

    INDUSTRIALS • CONGLOMERATES • NASDAQ

    $3.76
    -0.09 (-2.34%)

    Market Cap: $28.70M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Harte Hanks Inc (HHS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Harte Hanks (HHS) has a market cap of $28.70M and an enterprise value of $32.63M. It earned -$4.94M on revenue of $154.58M over the last 12 months.

    Total Valuation

    Enterprise value is 13.70% above the market cap, as debt exceeds cash.

    Market Cap$28.70M
    Enterprise Value$32.63M
    Latest price (Nov 17, 2026)$3.76

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.31% in the quarter ended Sep 30, 2026 and grew 0.88% a year over 2 years.

    Shares Outstanding7.45M
    Shares Change (YoY)+0.53%
    Shares Change (QoQ)+0.31%
    Share Count Growth (2Y CAGR)+0.88%

    Valuation Ratios

    Sales and book value multiples are 0.2x and 2.0x. Its year-end P/S ranged from 0.1x to 0.4x from 2016 to 2025.

    P/S Ratio0.2x
    P/B Ratio2.0x
    P/TBV Ratio2.1x

    Valuation history and multiples

    Price Statistics

    The stock is up 26.17% over 52 weeks and trades 11.53% below its 50-day average.

    Beta (1Y)0.49
    52-Week Change+26.17%
    1-Month Change-13.76%
    3-Month Change-0.53%
    6-Month Change+44.62%
    5-Year Change-46.62%
    10-Year Change-72.55%
    Total Return (1Y)+26.17%
    Total Return (3Y CAGR)-18.94%
    Total Return (5Y CAGR)-15.44%
    Return vs SPY (1Y)+23.69%
    Max Drawdown (1Y)-46.95%
    Max Drawdown (3Y)-77.25%
    Sharpe Ratio (1Y)0.44
    Correlation with SPY (1Y)0.10
    50-Day Average$4.25
    200-Day Average$3.13
    52-Week Range$2.00 to $4.67
    RSI (14 Days)34.9
    Average Volume (20 Days)52.41K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.23x current liabilities, and total debt is 0.45x shareholder equity.

    Current Ratio1.23x
    Quick Ratio1.23x
    Debt / Equity0.45x

    Returns and Efficiency

    Return on invested capital is -25.01% over the last 12 months, against a 5-year average of -2.98%.

    Return on Equity (ROE)-34.96%
    Return on Assets (ROA)-5.60%
    Return on Invested Capital (ROIC)-25.01%
    Return on Capital Employed (ROCE)-15.73%
    ROA (5Y Average)2.52%
    ROIC (5Y Average)-2.98%
    Asset Turnover1.71x
    Receivables Turnover4.12x

    Scores

    HHS has an Altman Z-Score of 14.62, in the safe zone above 2.99, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score14.62
    Altman Z ZoneSafe
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $154.58M over the last 12 months is down 7.35% from the 12 months before.

    Revenue$154.58M
    Revenue Growth (YoY)-7.35%
    Gross Profit$73.35M
    Operating Income-$7.16M
    Pretax Income-$8.20M
    Net Income-$4.94M
    EBITDA-$3.60M
    EBIT-$7.86M
    Reported EPS (TTM)-$0.66

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 16.02% of the $88.15M in total assets.

    Cash and Equivalents$2.37M
    Total Debt$6.30M
    Net Debt$3.93M
    Net Debt Per Share$0.53
    Working Capital$8.85M
    Shareholder Equity$14.12M
    Book Value Per Share$1.89
    Tangible Book Value$13.60M
    Tangible Book Per Share$1.83
    Total Assets$88.15M
    Total Liabilities$74.03M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.86M of capital spending, operating cash flow left -$9.87M of free cash flow.

    Operating Cash Flow-$8.01M
    Capital Expenditures$1.86M
    Free Cash Flow-$9.87M
    FCF Per Share-$1.32
    Depreciation and Amortization$4.26M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -4.63%, against a 5-year average of 2.88%.

    Gross Margin47.45%
    Operating Margin-4.63%
    Pretax Margin-5.30%
    Net Margin-3.19%
    EBITDA Margin-2.33%
    EBIT Margin-5.09%
    FCF Margin-6.39%
    Gross Margin (5Y Average)48.07%
    Operating Margin (5Y Average)2.88%
    Net Margin (5Y Average)1.57%

    Growth

    Revenue fell 8.20% a year over 3 years.

    Revenue Growth (3Y CAGR)-8.20%
    Revenue Growth (5Y CAGR)-2.04%
    Operating Income Growth (3Y CAGR)-70.55%
    Book Value Per Share Growth (2Y CAGR)+0.51%
    Tangible Book Per Share Growth (2Y CAGR)+13.33%

    Revenue and profit by year

    Dividends and Yields

    HHS does not pay a dividend. Its free cash flow yield is -35.22%.

    FCF Yield-35.22%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-10 reverse split on Feb 1, 2018.

    Last Split DateFeb 1, 2018
    Split TypeReverse split
    Split Ratio1:10

    Peer Position

    Against 10 similar companies, HHS has the 9th highest P/S.

    P/S Ratio0.2x vs 0.6x median
    ROIC-25.01% vs -3.42% median
    Revenue Growth (Trailing 4 Quarters, YoY)-7.35% vs +13.92% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About HHS

    What is HHS's market cap?

    Harte Hanks has a market cap of $28.70M. Its enterprise value, which adds debt and subtracts cash, is $32.63M.

    How many shares of HHS are outstanding?

    Harte Hanks has 7.45M shares outstanding. The count is up 0.53% from a year earlier.

    Does HHS pay a dividend?

    No. Harte Hanks does not pay a dividend.

    How much debt does HHS have?

    Harte Hanks has $6.30M of total debt and $2.37M of cash and equivalents, a net debt position of $3.93M.